Pınar İbrahim E, Ozkocaman V. Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma. Eur Res J. 2023;9(6):1483-1492. doi:10.18621/eurj.1359362